Pulse Biosciences (PLSE) Accounts Payables (2015 - 2025)

Pulse Biosciences has reported Accounts Payables for 11 years, with the latest figure at $2.8 million in Q4 2025.

• For the quarter ending Q4 2025, Accounts Payables rose 65.99% year-over-year to $2.8 million; the trailing twelve-month figure through Dec 2025 stood at $2.8 million (up 65.99% YoY), and the FY2025 full-year result was $2.8 million, up 65.99% from the prior year.
• Accounts Payables for Q4 2025 stood at $2.8 million, down from $3.0 million in the prior quarter.
• The five-year high for Accounts Payables was $3.5 million in Q1 2022, with the low at $1.4 million in Q3 2023.
• Average Accounts Payables over 5 years is $2.2 million, with a median of $2.0 million recorded in 2022.
• Year-over-year, Accounts Payables jumped 89.59% in 2021 and tumbled 38.04% in 2023.
• Tracing PLSE's Accounts Payables over 5 years: stood at $1.8 million in 2021, then decreased by 14.32% to $1.6 million in 2022, then gained by 16.72% to $1.8 million in 2023, then slipped by 8.88% to $1.7 million in 2024, then surged by 65.99% to $2.8 million in 2025.
• The last three Accounts Payables figures came in at $2.8 million (Q4 2025), $3.0 million (Q3 2025), and $2.7 million (Q2 2025), per Business Quant data.

Peer Comparison